Cargando…
Clinical characteristics and antithrombotic prescription in elderly hospitalized atrial fibrillation patients: A cross-sectional analysis of a Swedish single-center clinical cohort
BACKGROUND: Antithrombotic treatment represents a dilemma in elderly patients with atrial fibrillation since both risk of thromboembolism and bleeding are age-dependent complications. A paradigm shift occurred over the past 10 years when aspirin was overcome by warfarin and further by the direct ora...
Autores principales: | Ehrlinder, Hanne, Orsini, Nicola, Modig, Karin, Hofman-Bang, Claes, Wallén, Håkan, Gigante, Bruna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114891/ https://www.ncbi.nlm.nih.gov/pubmed/32258363 http://dx.doi.org/10.1016/j.ijcha.2020.100505 |
Ejemplares similares
-
Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
por: Ehrlinder, Hanne, et al.
Publicado: (2022) -
Is the association of QTc with atrial fibrillation and stroke in cohort studies a matter of time?
por: Radnahad, Navid, et al.
Publicado: (2022) -
Elevated Uric Acid Is Associated With New‐Onset Atrial Fibrillation: Results From the Swedish AMORIS Cohort
por: Ding, Mozhu, et al.
Publicado: (2023) -
Lipid levels in midlife and risk of atrial fibrillation over 3 decades—Experience from the Swedish AMORIS cohort: A cohort study
por: Ding, Mozhu, et al.
Publicado: (2022) -
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)